Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

What other immunotherapy options are there in recurrent metastatic disease?

Beyond the use of checkpoint inhibitor

Date

17 Oct 2020

Session

What other immunotherapy options are there in recurrent metastatic disease?

Topics

Immunotherapy

Tumour Site

Presenters

Ezra Cohen

Authors

E. Cohen

Author affiliations

  • Moores Cancer Center - UC San Diego Health, 92093 - La Jolla/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Immunotherapy in NPC

Presenter: Brigette Ma

Session: What other immunotherapy options are there in recurrent metastatic disease?

Resources:

Slides

Webcast

Q&A and live discussion

Presenter: Ana Martins Ferreira Castro

Session: What other immunotherapy options are there in recurrent metastatic disease?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.